DNA ploidy and pS2 protein expression in breast cancer

Cytopathology

Volumn 8, Issue 3, 1997, Pages 171-176

  Ioakim Liossi, A ^a,d   Karakitsos, P ^b   Aroni, K ^a   Markopoulos, C ^c   Delivelioti, K ^b   Gogas, J ^c   Kyrkou, K ^c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d NONE   (Greece)

Author keywords

Breast cancer; DNA ploidy; pS2 protein

Indexed keywords

DNA; ESTROGEN; PROTEIN; TFF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BREAST CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; ANEUPLOIDY; BREAST; BREAST TUMOR; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; PAGET NIPPLE DISEASE; PATHOLOGY; PROSPECTIVE STUDY;

ANEUPLOIDY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMAGE CYTOMETRY; IMMUNOHISTOCHEMISTRY; PLOIDIES; PROSPECTIVE STUDIES; PROTEINS; TUMOR SUPPRESSOR PROTEINS;

EID: 0030610622     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.1997.44175441.x     Document Type: Article

References (25)

1. Rio MC, Bellocq JP, Gairard B et al. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 1987; 84: 9243-7.
2. 2. C. R. Acad Sci Paris 1988; 307: 825-31.
3. Hoosein NM, Thim L, Jorgensen KH, Brettain MG. Growth stimulatory effect of pancreatic spasmolytic polypeptide on cultured colon and breast tumor cells. FEBS Letter 1989; 247: 303-6.
4. 2 protein relevant to growth of human breast cancer cells (MCF-7). Cancer Res 1989; 49: 3494-8.
5. Bloom HJB, Richardson WW. Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-77.
6. Schwartz LH, Koerner FC, Edgerton SM et al. pS2 expression and response to hormonal therapy in patients with advanced breast cancer. Cancer Res 1991; 51: 624-8.
7. Auer GU, Falkmer UG, Zetterberg AD. Image cytometric nuclear DNA analysis in clinical tumour material. In: Baak JPA, ed. Manual of Quantitative Pathology in Canter Diagnosis and Prognosis. Berlin: Springer-Verlag, 1991: 218-20.
8. Henry JA, Piggott NH, Mallick UK et al. pNR-2/ pS2 immunohistochemical staining in breast cancer: correlation with prognostic factors and endocrine response. Br J Cancer 1991; 63: 615-22.
9. Detre S, King N, Salter J, MacLennan K, McKinna JA, Dowsett M. Immunohistochemical and biochemical analysis of the oestrogen regulated protein pS2, and its relation with oestrogen receptor and progesterone receptor in breast cancer. J Clin Pathol 1994; 47: 240-4.
10. 2 peptide in primary breast carcinomas: comparison of membrane and cytoplasmic staining patterns. J Pathol 1993; 171: 123-9.
11. Ibrahim NBN, Padfield CJH, Rees EJ, Wilson Y, Cawthorn SJ. Immunocytochemistry in the assessment of pS2 protein expression in fine needle aspiration cytology from breast carcinoma. Cytopathology 1993; 4: 323-30.
12. Henry SA, Nicholson S, Hennessy C, Lennard TWJ, May FEB, Westley BR. Expression of the oestrogen regulated pNR-2mRA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 1990; 61: 32-38.
13. 2 protein in breast cancer cytosol. Clin Chem 1991; 37: 1759-62.
14. 2 status in association with steroid receptor status and proliferative activity in node-negative breast cancer. Eur J Cancer 1992; 28A: 1315-8.
15. Predine J, Spyretos F, Prud'homme JF et al. Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors and normal breast tissues. Cancer 1992; 69: 2116-23.
16. Pallud C, Doussal V, Pichon MF, Prud'homme JF, Hacene K, Milgrom E. Immunohistochemistry of pS2 in normal human breast and in various histological forms of breast tumours. Histopathology 1993; 23: 249-56.
17. Thor AD, Koerner FC, Edgerton SM, Wood WC, Stracher MA, Schwartz LA. pS2 expression in primary breast carcinomas, relationship to clinical and histological features and survival. Breast Cancer Res Treat 1992; 21: 111-9.
18. Foekens JA, Van Putten WLJ, Portengen H et al. Prognostic value of pS2 and cathepsin-d in 710 human primary breast tumors: mullivariate analysis. J Clin Oncol 1993; 11: 899-908.
19. Spyratos F, Andrieu C, Hacene K, Chambon P, Rio MC. pS2 and response to adjuvant hormone therapy in primary breast cancer. Br J Cancer 1994; 69: 394-7.
20. Grombach G, Ingenhorst A, Goehring UJ et al. Expression of pS2 protein in breast cancer. Arch Gynecol Obstet 1993; 253: 183-92.
21. Thompson AM, Howkins RA, Elton RA, Steel CM, Chetty U, Carter DC. pS2 is an independent factor of good prognosis in primary breast cancer. Br J Cancer 1993; 68: 93-96.
22. Furlong JW. DNA analysis of breast. In: Keren DF, Hanson CA, Hurtubis PE, eds. Flow Cytometry and Clinical Diagnosis. Chicago: ASCP Press, 1994: 543-4.
23. Susnik B, Poulin, Phillips D, LeRiche J, Palcie B. Comparison of DNA measurement performed by flow and image cytometry of embedded breast tissue sections. Analyt Quant Cytol Histol 1995; 17: 163-71.
24. Guzman J, Ruckmann A, Glaser A, Wittekind C, Schonfeld B, Kiefer G. DNA cytophotometric analysis of breast cancer: follow-up for 10 years. Anal Quant Cytol Histol 1992; 14: 427-32.
25. Devilee P, Thierry R, Kievitis T et al. Detection of chromosome aneuploidy in interphase nuclei from human primary breast tumors using chromosome-specific repetitive DNA probes. Cancer Res 1988; 48: 5825-30.